These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 838420)

  • 1. [The copper IUD as an alternative to the "pill". Experiences with the intrauterine device Gyne-T].
    Heister VR
    Fortschr Med; 1977 Jan; 95(3):186-8. PubMed ID: 838420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine contraception.
    Reinprayoon D
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):527-30. PubMed ID: 1324024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IUD insertion during cesarean section and its most frequent complications].
    Alvarez Pelayo J; Borbolla Sala ME
    Ginecol Obstet Mex; 1994 Nov; 62():330-5. PubMed ID: 7821830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intrauterine contraception in nulliparous women].
    Prilepskaia VN; Mezhevitinova EA
    Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contraindications for the use of copper T intrauterine pessaries].
    Wagner H; Schmidt EH
    Med Welt; 1976 Aug; 27(35):1631-4. PubMed ID: 957993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three years experience with copper T-200.
    Kanitkar SD; Tare VS; Tambay PY; Mutatkar KR
    J Indian Med Assoc; 1983 May; 80(9-10):148-9. PubMed ID: 6644055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrauterine contraception from the viewpoint of an ambulatory gynecologic department].
    Hagen P
    Z Arztl Fortbild (Jena); 1981 Sep; 75(17):800-4. PubMed ID: 7345787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women.
    Srisupandit S
    J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Gravigard intrauterine copper contraceptive device.
    Macourt DC
    Med J Aust; 1974 May; 1(18):717-8. PubMed ID: 4851932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience with Gyne-T Cu 380-A, an intrauterine contraceptive device (1983-1984)].
    Beric B; Aleksic S; Marjanovic M; Kranz F
    Contracept Fertil Sex (Paris); 1985 May; 13(5):717-9. PubMed ID: 12267100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.